Management of Ileitis in Patients with Colon Cancer

Initial Diagnostic Approach

The American Gastroenterological Association recommends determining the etiology of ileitis immediately through clinical context and imaging, particularly in patients who are neutropenic post-chemotherapy, to suspect neutropenic enterocolitis, which carries high mortality risk due to rapid progression to perforation and multisystem organ failure 1, 2
Cross-sectional imaging (CT or MRI) should be obtained to assess bowel wall thickening, dilation, presence of local mass, abscess formation, or perforation, as recommended by the European Society of Gastrointestinal Endoscopy 1, 2
The American College of Gastroenterology advises against colonoscopy in neutropenic patients as it carries very high perforation risk 1, 2, 3
Infectious causes, including C. difficile, CMV, Candida, and bacterial pathogens, should be ruled out through stool studies and potentially endoscopic biopsies if safe, as suggested by the Infectious Diseases Society of America 1, 3, 4

The European Society for Medical Oncology recommends conservative management with bowel rest, IV fluids, and parenteral nutrition for most patients with inflammation limited to cecum and terminal ileum 1, 2
Broad-spectrum antibiotics should be administered to cover bacterial invasion of the inflamed bowel wall, as advised by the American Society of Clinical Oncology 1, 2, 4
Normalizing neutrophil counts with growth factor support is crucial, as recommended by the National Comprehensive Cancer Network 1, 2
Frequent clinical reassessment and early surgical consultation are necessary from the outset, as suggested by the Society of Surgical Oncology 1, 2

The American Gastroenterological Association recommends additional small bowel imaging (CT/MR enterography) to differentiate from Crohn's disease and assess extent, in patients with backwash ileitis 5, 6
Patients with backwash ileitis are prone to more refractory disease and increased risk of colon neoplasia, as noted by the Crohn's and Colitis Foundation 5, 6

The American College of Surgeons advises against delaying treatment while awaiting diagnostic studies in a neutropenic patient with suspected enterocolitis, as mortality is high with rapid progression 1, 2
The American Society for Gastrointestinal Endoscopy recommends against performing colonoscopy in neutropenic patients due to extreme perforation risk 1, 2, 3
The European Society of Gastrointestinal Endoscopy advises against using anti-diarrheal medications in severe colitis or neutropenic enterocolitis, although this recommendation is based on a lower level of evidence 7